secwatch.observer — SEC 8-K summary
======================================

Issuer:     GERON CORP (GERN)
CIK:        0000886744
Form:       8-K
Filed at:   2024-01-30T23:59:59+00:00
Accession:  0000950170-24-008536
Event type: regulatory
Sentiment:  neutral
Materiality: 0.75
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

FDA schedules advisory committee meeting for Geron's imetelstat NDA on March 14, 2024
--------------------------------------------------------------------------------

- FDA's Oncologic Drugs Advisory Committee will review imetelstat for transfusion-dependent anemia in lower-risk MDS on March 14, 2024.
- Meeting is scheduled from 9:30 a.m. to 3:00 p.m. ET, and will be open to the public.
- PDUFA action date for the NDA remains June 16, 2024.
- Federal Register notice published January 30, 2024 provides details of the advisory committee meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/886744/000095017024008536/0000950170-24-008536-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/886744/000095017024008536/gern-20240130.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-008536

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer